IDEAYA director granted options on 20,000 shares
IDEAYA Biosciences director Wendy L. Yarno received a grant of stock options for 20,000 shares of common stock at an exercise price of $30.57 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IDEAYA Biosciences director Wendy L. Yarno received a grant of stock options for 20,000 shares of common stock at an exercise price of $30.57 per share. The options vest 100% on the earlier of one year from grant or immediately before the next Annual Meeting, subject to continued Board service, and expire on June 16, 2036.
Insider Trade Summary
Grant/Award: 20,000 shares
Grant/Award
1 txn
Insider
YARNO WENDY L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 20,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.
Key Figures
Option grant size: 20,000 shares
Exercise price: $30.57 per share
Total derivative shares after grant: 20,000 shares
+2 more
5 metrics
Option grant size
20,000 shares
Underlying common stock in new stock option award
Exercise price
$30.57 per share
Strike price of stock option grant
Total derivative shares after grant
20,000 shares
Derivative securities following transaction
Option expiration date
June 16, 2036
End of option term
Vesting schedule
100% cliff vesting
Earlier of one year from grant or before next Annual Meeting
Key Terms
Stock Option (right to buy), Common Stock, Annual Meeting, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Annual Meeting financial
"immediately prior to the Annual Meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
vesting financial
"100% of the shares subject to the option shall vest in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price": "30.5700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IDEAYA Biosciences (IDYA) report for Wendy L. Yarno?
IDEAYA Biosciences reported that director Wendy L. Yarno received a stock option grant covering 20,000 shares of common stock at an exercise price of $30.57 per share. This is a compensation-related equity award, not an open-market stock purchase or sale.
What is the exercise price and term of Wendy Yarno’s IDEAYA stock options?
Wendy Yarno’s IDEAYA stock options have an exercise price of $30.57 per share and an expiration date of June 16, 2036. These options give her the right to buy IDEAYA common stock at that price once they are vested and exercised.
When do Wendy Yarno’s IDEAYA (IDYA) stock options vest?
All 20,000 stock options granted to Wendy Yarno vest 100% on the earlier of the first anniversary of the grant date or immediately before the Annual Meeting following the grant. Vesting is conditioned on her continued service on IDEAYA’s Board through that vesting date.
Is Wendy Yarno’s IDEAYA Form 4 transaction a market buy or sell?
The Form 4 reports a grant of stock options as compensation, coded as a grant or award acquisition. It is not an open-market buy or sell of IDEAYA common stock, but the creation of an option position she may later exercise, subject to vesting and expiration.
How many IDEAYA derivative securities does Wendy Yarno hold after this grant?
After the transaction, Wendy Yarno holds derivative securities representing 20,000 shares through the stock option award. The Form 4 shows 20,000 derivative shares following the transaction, reflecting this newly granted option position and no additional derivative holdings in the excerpt.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates